67 related articles for article (PubMed ID: 28881047)
1. Podoplanin expression in cancer-associated fibroblasts predicts unfavourable prognosis in patients with pathological stage IA lung adenocarcinoma.
Kubouchi Y; Yurugi Y; Wakahara M; Sakabe T; Haruki T; Nosaka K; Miwa K; Araki K; Taniguchi Y; Shiomi T; Nakamura H; Umekita Y
Histopathology; 2018 Feb; 72(3):490-499. PubMed ID: 28881047
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of predominant subtype in pathological stage II-III lung adenocarcinoma with epidermal growth factor receptor mutation.
Kitagawa S; Zenke Y; Taki T; Aokage K; Sakai T; Shibata Y; Izumi H; Nosaki K; Umemura S; Matsumoto S; Yoh K; Sakamoto N; Sakashita S; Kojima M; Tsuboi M; Goto K; Ishii G
Lung Cancer; 2024 Feb; 188():107453. PubMed ID: 38160515
[TBL] [Abstract][Full Text] [Related]
3. Progressive changes in the protein expression profile of alveolar septa in early-stage lung adenocarcinoma.
Kimura T; Akazawa T; Mizote Y; Nakamura H; Sakaue M; Maniwa T; Shintani Y; Honma K; Tahara H; Okami J
Int J Clin Oncol; 2024 Jun; 29(6):771-779. PubMed ID: 38600426
[TBL] [Abstract][Full Text] [Related]
4. BRMS1 Expression in Surgically Resected Lung Adenocarcinoma Predicts Future Metastases and Is Associated with a Poor Prognosis.
Bucciarelli PR; Tan KS; Chudgar NP; Brandt W; Montecalvo J; Eguchi T; Liu Y; Aly R; Travis WD; Adusumilli PS; Jones DR
J Thorac Oncol; 2018 Jan; 13(1):73-84. PubMed ID: 29097253
[TBL] [Abstract][Full Text] [Related]
5. Micropapillary or solid component predicts worse prognosis in pathological IA stage lung adenocarcinoma: A meta-analysis.
Wang Y; Hu J; Sun Y; Lu Y
Medicine (Baltimore); 2023 Dec; 102(49):e36503. PubMed ID: 38065873
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the preoperative neutrophil-to-lymphocyte ratio as a predictor of the micropapillary component of stage IA lung adenocarcinoma.
Chen C; Chen ZJ; Li WJ; Deng T; Le HB; Zhang YK; Zhang BJ
J Int Med Res; 2024 Apr; 52(4):3000605241245016. PubMed ID: 38661098
[TBL] [Abstract][Full Text] [Related]
7. Expression of CUB domain containing protein (CDCP1) is correlated with prognosis and survival of patients with adenocarcinoma of lung.
Ikeda J; Oda T; Inoue M; Uekita T; Sakai R; Okumura M; Aozasa K; Morii E
Cancer Sci; 2009 Mar; 100(3):429-33. PubMed ID: 19077003
[TBL] [Abstract][Full Text] [Related]
8. Cytological features of stromal spindle cells and their prognostic significance in lung adenocarcinoma.
Miyata-Morita K; Morita S; Dejima H; Saito K; Sakao Y; Mochizuki M; Sasajima Y
Cytopathology; 2023 Jul; 34(4):337-345. PubMed ID: 36946097
[TBL] [Abstract][Full Text] [Related]
9. Cancer-associated fibroblasts expressing fibroblast activation protein and podoplanin in non-small cell lung cancer predict poor clinical outcome.
Mathieson L; Koppensteiner L; Dorward DA; O'Connor RA; Akram AR
Br J Cancer; 2024 May; 130(11):1758-1769. PubMed ID: 38582812
[TBL] [Abstract][Full Text] [Related]
10. Oncogenic phosphatase Wip1 is a novel prognostic marker for lung adenocarcinoma patient survival.
Satoh N; Maniwa Y; Bermudez VP; Nishimura K; Nishio W; Yoshimura M; Okita Y; Ohbayashi C; Hurwitz J; Hayashi Y
Cancer Sci; 2011 May; 102(5):1101-6. PubMed ID: 21281403
[TBL] [Abstract][Full Text] [Related]
11. TTF-1 status in early-stage lung adenocarcinoma is an independent predictor of relapse and survival superior to tumor grading.
Schallenberg S; Dernbach G; Dragomir MP; Schlachtenberger G; Boschung K; Friedrich C; Standvoss K; Ruff L; Anders P; Grohé C; Randerath W; Merkelbach-Bruse S; Quaas A; Heldwein M; Keilholz U; Hekmat JK; Rückert C; Büttner R; Horst D; Klauschen F; Frost N
Eur J Cancer; 2024 Jan; 197():113474. PubMed ID: 38100920
[TBL] [Abstract][Full Text] [Related]
12. The Combination Of Weak Expression Of PRDX4 And Very High MIB-1 Labelling Index Independently Predicts Shorter Disease-free Survival In Stage I Lung Adenocarcinoma.
Shioya A; Guo X; Motono N; Mizuguchi S; Kurose N; Nakada S; Aikawa A; Ikeda Y; Uramoto H; Yamada S
Int J Med Sci; 2018; 15(10):1025-1034. PubMed ID: 30013444
[No Abstract] [Full Text] [Related]
13. Expression of podoplanin, CD44, and p63 in squamous cell carcinoma of the lung.
Shimada Y; Ishii G; Nagai K; Atsumi N; Fujii S; Yamada A; Yamane Y; Hishida T; Nishimura M; Yoshida J; Ikeda N; Ochiai A
Cancer Sci; 2009 Nov; 100(11):2054-9. PubMed ID: 19681903
[TBL] [Abstract][Full Text] [Related]
14. Cancer-associated fibroblast phenotypes are associated with patient outcome in non-small cell lung cancer.
Cords L; Engler S; Haberecker M; Rüschoff JH; Moch H; de Souza N; Bodenmiller B
Cancer Cell; 2024 Mar; 42(3):396-412.e5. PubMed ID: 38242124
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological Significance of DUB3 Expression in Non-small Cell Lung Cancer and Relationship Between DUB3 Expression and LATS1 Expression.
Jang SH; Cho HD; Lee JH; Oh MH
In Vivo; 2023; 37(5):2296-2305. PubMed ID: 37652526
[TBL] [Abstract][Full Text] [Related]
16. Different types of tumor microvessels in stage I-IIIA squamous cell lung cancer and their clinical significance.
Senchukova MA; Kalinin EA; Volchenko NN
World J Clin Oncol; 2024 May; 15(5):614-634. PubMed ID: 38835849
[TBL] [Abstract][Full Text] [Related]
17. Estimating the cure proportion of stage IA lung adenocarcinoma: a population-based study.
Huang Z; Chen D; Hong Z; Kang M
BMC Pulm Med; 2023 Oct; 23(1):417. PubMed ID: 37907906
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of tumor budding in patients with pancreatic invasive ductal carcinoma who received neoadjuvant therapy.
Ibuki E; Kadota K; Kimura N; Ishikawa R; Oshima M; Okano K; Haba R
Heliyon; 2024 Jan; 10(1):e23928. PubMed ID: 38205326
[TBL] [Abstract][Full Text] [Related]
19. Histological and prognostic data on surgically resected early-stage lung adenocarcinoma.
Yotsukura M; Asamura H; Suzuki S; Asakura K; Yoshida Y; Nakagawa K; Sakurai H; Watanabe SI; Motoi N
Data Brief; 2020 Aug; 31():105785. PubMed ID: 32551350
[TBL] [Abstract][Full Text] [Related]
20. Spatiotemporal architecture of immune cells and cancer-associated fibroblasts in high-grade serous ovarian carcinoma.
Xu AM; Haro M; Walts AE; Hu Y; John J; Karlan BY; Merchant A; Orsulic S
Sci Adv; 2024 Apr; 10(16):eadk8805. PubMed ID: 38630822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
